Health CanadaGeneral Alert
Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
Published: January 7, 2022Recall ID: 63799Category: generalCountry: Canada
Safety AlertHealth CanadaCanada
CanadaCasirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
Recalling Firm: Marketed health products
Reason for Recall / Hazard
New safety information - COVID
Product Description & Identification
Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
Affected Products
Casirivimab and Imdevimab
Additional Source Details
| Field | Value |
|---|---|
| N I D | 63799 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/casirivimab-and-imdevimab-high-risk-treatment-failure-due-circulation-sars-cov-2 |
| Issue | New safety information - COVID |
| Title | Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant |
| Product | Casirivimab and Imdevimab |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2022-01-07 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant Check if your household is affected: https://therecallfile.com/recalls/casirivimab-and-imdevimab-high-risk-of-treatment-failure-due-to-circul/CANADA-63799
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Featured on Product Hunt
Help support our public safety mission and check out our community launch.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordCasirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
Related Recalls
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018088 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018088 -
Tires
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018288 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018288 -
Airbag
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018409 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018409 -
Airbag
—TC